Surgery Partners, Inc.
SGRYNASDAQHealthcareMedical Care Facilities
As of Oct 22, 2026 close
- Market cap
- $2.05B
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $11.41$23.44
- Volume (live)
- -
- Avg. volume (3M)
- 2.11M
Surgery Partners (SGRY) Stock Price & Financial Analysis
Surgery Partners Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $15.35 - $16.00 |
|---|---|
| 52-Week High | $23.44 |
| 52-Week Low | $11.41 |
| Open | $15.52 |
| Volume (last close) | 2.91M |
| Average Volume (3M) | 2.11M |
| Revenue (TTM) | 3.37B |
|---|---|
| Net Income (TTM) | -88.60M |
| Free Cash Flow (TTM) | 187.60M |
| EPS (TTM) | −$0.69 |
| Profit Margin | -2.63% |
| Operating Margin | 12.37% |
| Return on Equity (ROE) | -2.55% |
| Debt to Equity | 1.08 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 2.05B |
|---|---|
| Shares Outstanding | 128.82M |
| Price to Sales (P/S) | 0.61 |
| Price to Book (P/B) | 0.59 |
| EV/EBITDA | 9.10 |
| 50-Day MA | $14.20 |
|---|---|
| 200-Day MA | $14.44 |
| 1-Year Change | −27.63% |
Source: Market prices and company fundamentals. Data as of Oct 22, 2026. Data sources and methodology
Surgery Partners at a Glance
As of the Oct 22, 2026 close, Surgery Partners (SGRY) has a market capitalization of $2.05B. The stock trades at 0.6× sales. Over the trailing twelve months it lost $88.60M on revenue of $3.37B and generated $187.60M of free cash flow. Revenue grew 4.0% year over year.
As of its latest reported balance sheet, it holds $216.70M in cash and securities against $3.75B of debt, a net debt position of $3.53B.
Surgery Partners does not currently pay a dividend.
The share price is down 27.6% over the past year. At $15.90 (the Oct 22, 2026 close) it sits within its 52-week range of $11.41 to $23.44, above its 200-day moving average of $14.44.
Based on 10 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $18.43, 15.9% above the Oct 22, 2026 close.
Frequently Asked Questions About Surgery Partners
What is the current stock price for SGRY?
As of the Oct 22, 2026 close, SGRY stock trades at $15.90. The 52-week range is $11.41–$23.44, with a day range of $15.35–$16.00.
What is the P/E ratio for SGRY?
The P/E ratio (Price-to-Earnings) for SGRY is shown in the Key Statistics section. This valuation metric helps compare Surgery Partners, Inc. to industry peers.
Does SGRY pay dividends?
Surgery Partners does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for SGRY?
Based on ratings from 10 professional analysts over the last 90 days, the consensus for SGRY is Buy. The average 12-month price target is $18.43, a 15.9% upside from the Oct 22, 2026 close of $15.90.
What is the market cap of SGRY?
As of the Oct 22, 2026 close, Surgery Partners's market capitalization is $2.05B, classifying it as a mid-cap company. Surgery Partners operates in the Healthcare sector within the Medical Care Facilities industry.